Sales

In a recent announcement, the Food and Drug Administration granted approval for Moderna’s vaccine for respiratory syncytial virus (RSV) for adults aged 60 and older. This marks a significant milestone for Moderna, as it diversifies its product portfolio beyond its Covid jab, which has seen a decrease in demand. The decision to approve Moderna’s RSV
0 Comments
The Municipal Bond market experienced a surge in issuance in May, surpassing $40 billion for the first time since 2016. The current volume of $43.957 billion in 866 issues represents a significant increase of 46.9% from the previous year. This surge in issuance can be attributed to several factors, including Federal Reserve policy uncertainty, pent-up
0 Comments
The U.S. dollar experienced a slight rise in early European trade, bouncing back from previous losses in anticipation of key inflation data. The Dollar Index, which tracks the greenback against a basket of six other currencies, showed a 0.1% increase to 104.735. This movement followed a dip to 104.63 overnight, highlighting the volatility in currency
0 Comments